ITMCTR2100005008招募中2 期
Clinical Efficacy of Xiaoqinglong Decoction in Treatment of Eosinophilic Nasal Polyp and Mechanism of Reducing Th2 Inflammatory Factors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 70(—)
- 性别
- All
入选标准
- •1. Subjects must voluntarily participate in this study and abide by the study regulations, understand and abide by the medication dosage, follow up plan, correctly record adverse event records, and voluntarily sign the written informed consent;
- •2. Aged 18 to 70 years old male and female;
- •3. Diagnostic criteria are based on the CRS diagnostic criteria for nasal polyps associated with European Guidelines for the Diagnosis and Treatment of Rhinosinusitis and Nasal Polyps 2020. This included subjective evaluation, endoscopy and imaging examination of patients;
- •4. Patients with VAS score 3 to 7 and polyps >=1 in Lund-Kennedy score of nasal endoscopy;
- •5. The mucosal tissues of nasal polyps were stained with HE. At high magnification, eosinophils >=10% of total inflammatory cells.
排除标准
- •1. Pregnant or lactating women;
- •2. Subjects had cystic fibrosis, congenital ciliary dyspraxia, non-invasive fungal balls and invasive mycosis, systemic vasculitis and granulomatous disease, tumor patients, immunodeficiency, and allergic fungal sinusitis;
- •3. The subject is allergic to hormones;
- •4. Subjects with other autoimmune diseases are receiving long-term immunosuppressive drug therapy;
- •5. Subjects are suffering from respiratory tract infection;
- •6. Clinically serious metabolic, cardiovascular, immune, neurological, hematological, digestive, cerebrovascular, or respiratory diseases, or any disease considered by the Investigator to interfere with the evaluation of study results or affect the safety of subjects;
- •7. Currently participating in other clinical studies or participating in other clinical investigators within 30 days, or directly participating in the study staff;
- •8. Having a history of mental illness, antagonistic personality, bad motivation, paranoia or other emotional or intellectual problems may affect the informed effectiveness of study participants;
- •9. Other CRS drugs or other treatments, such as nasal irrigation, were administered topically and systemically during the first 4 weeks of the trial.
研究者
相似试验
暂停
不适用
Clinical study of Modified Xiaochengqi Decoction in perioperative period of biliary tract surgery: A Randomized Controlled TrialITMCTR2000003321Affiliated Hospital of Binzhou Medical College
招募中
不适用
Clinical research of Xinglou Chengqi Decoction on improving post-stroke cognitive impairment due to phlegm heat and viscera excess syndrome based on brain-gut interactioPost-stroke Cognitive ImpairmentITMCTR2100004688Wenzhou Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine
招募中
1 期
Clinical study of Qinzhu Liangxue Decoction in the treatment of atopic dermatitis: a randomized controlled trial.atopic dermatitisITMCTR2000003981Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
招募中
1 期
Clinical study on Zhou's Qiling Decoction inducing apoptosis of prostate cancer cells through miR-143 / Bcl-2 pathwayProstate cancerITMCTR2100004269Surgical Department I (Urology Department), Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
招募中
不适用
Clinical study on Qinghua Liangxue Huayu Decoction combined with Shuigutie in the treatment of chronic liver failure complicated with ascites heat toxin and blood stasis syndromeChronic liver failureITMCTR2000003865Shanghai Municipal Hospital of TCM
